GlassScriptPhysician profile
Dwayne Douglas Henry
NPI 1952359077
$5,789.63
in general payments reported to CMS, 2019-2025
17 companies · $2,530 in 2025
The $2,530 reported for 2025 was more than what 90% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $726 · 2020: $202 · 2021: $332 · 2022: $471 · 2023: $623 · 2024: $905 · 2025: $2,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,707 · Travel and Lodging: $875 · Education: $327 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,707.32 |
| Travel and Lodging | $874.71 |
| Education | $326.96 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $2,132.54 | 2019-2025 | Xywav |
| Inspire Medical Systems, INC. | $1,844.83 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $990.23 | 2020-2025 | Wakix |
| Itamar Medical INC | $147.00 | 2021-2024 | Watchpatone |
| Eisai INC. | $125.00 | 2019 | |
| Glaxosmithkline, LLC. | $122.80 | 2019 | |
| Axsome Therapeutics, INC. | $110.52 | 2024-2025 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $55.09 | 2023-2025 | Lumryz |
| Travere Therapeutics, INC. | $50.08 | 2019 | |
| Lilly USA, LLC | $42.14 | 2025 | Zepbound |
| Cumberland Pharmaceuticals, INC. | $38.53 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $30.61 | 2019 | |
| Idorsia Pharmaceuticals US INC | $26.11 | 2023 | Quviviq |
| Arbor Pharmaceuticals, INC. | $23.69 | 2021 | |
| Csl Behring | $20.93 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $18.46 | 2019 | |
| Shire North American Group INC | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwayne Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.